Coleen Glessner - Apr 7, 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
EVP, Quality & Ethics, and CPL
Signature
/s/ Jennifer Lynne Fox, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Apr 7, 2024
Transactions value $
-$1,340
Form type
4
Date filed
4/9/2024, 07:27 PM
Previous filing
Mar 15, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Tax liability -$1.34K -585 -0.35% $2.29 164K Apr 7, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld to pay taxes.